These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
298 related items for PubMed ID: 6206005
21. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines. Hankey GJ. Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741 [Abstract] [Full Text] [Related]
22. In vivo platelet release in myeloproliferative disorders. Ireland H, Lane DA, Wolff S, Foadi M. Thromb Haemost; 1982 Aug 24; 48(1):41-5. PubMed ID: 6215739 [Abstract] [Full Text] [Related]
23. [Platelet activation in the early phases of acute myocardial infarction]. Salvioni A, Giraldi F, Assanelli E, Lauri G, Grazi M, Pardea S, Marenzi G. Cardiologia; 1998 Aug 24; 43(8):825-32. PubMed ID: 9808873 [Abstract] [Full Text] [Related]
24. Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implications. Wu KK, Hoak JC. Thromb Haemost; 1976 Jun 30; 35(3):702-11. PubMed ID: 989974 [Abstract] [Full Text] [Related]
25. Platelet behavior in patients with TIA: responsiveness to small doses of aspirin. D'Andrea G, Toldo M, Cananzi A, Cortelazzo S, Ferro-Milone F. Eur Neurol; 1985 Jun 30; 24(6):426-32. PubMed ID: 2933258 [Abstract] [Full Text] [Related]
26. Use of dipyridamole in patients with recent stroke or TIA. Bernstein RA. Am Fam Physician; 2005 Aug 01; 72(3):382, 384; author reply 384. PubMed ID: 16100852 [No Abstract] [Full Text] [Related]
27. Platelet release reaction in vivo in patients with ischaemic heart disease after isometric exercise and its prevention with dipyridamole. Sano T, Motomiya T, Yamazaki H. Thromb Haemost; 1980 Feb 29; 42(5):1589-97. PubMed ID: 6966082 [Abstract] [Full Text] [Related]
28. [Determination of the level of plasma beta-thromboglobulin in diabetes]. Stoltz JF, Voisin P, Drouin P, Pointel JP, Benisti G. Biomedicine; 1980 Feb 29; 33(6):194-6. PubMed ID: 6163487 [Abstract] [Full Text] [Related]
29. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected]. Kirshner HS. Int J Clin Pract; 2007 Oct 29; 61(10):1739-48. PubMed ID: 17877660 [Abstract] [Full Text] [Related]
30. Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack. McCabe DJ, Harrison P, Sidhu PS, Brown MM, Machin SJ. Br J Haematol; 2004 Sep 29; 126(6):861-9. PubMed ID: 15352991 [Abstract] [Full Text] [Related]
31. Beta-thromboglobulin and platelet aggregation in essential hypertension and the influence of prazosin therapy. Okrucká A, Pechán J, Mikulecký M. Cor Vasa; 1990 Sep 29; 32(5):363-73. PubMed ID: 2149548 [Abstract] [Full Text] [Related]
32. [Changes in serum beta-thromboglobulin levels during oral contraception, cardiac valve disease and pulmonary embolism (author's transl)]. Conard J, Terrier E, Baillet M, Horellou MH, Jaulmes B, Samama M, Baillet J. Nouv Presse Med; 1981 Apr 11; 10(16):1327-9. PubMed ID: 6164044 [Abstract] [Full Text] [Related]
33. A randomized clinical trial of pentoxifylline and antiaggregants in recent transient ischemic attacks (TIA). A one year follow-up. Herskovits E, Vazquez A, Famulari A, Tamaroff L, Fraiman H, Gonzáles AM, Smud R, Vila J, Matera V. Ric Clin Lab; 1981 Apr 11; 11 Suppl 1():257-64. PubMed ID: 6765140 [Abstract] [Full Text] [Related]
34. [Anti-platelet therapy in ischemic cerebrovascular disorder--clinical and hematological study]. Yoshii K, Seki Y, Aiba T, Tsukada T, Shiozawa R. No To Shinkei; 1985 Oct 11; 37(10):985-90. PubMed ID: 4074576 [Abstract] [Full Text] [Related]
35. Transient ischaemic attacks and increased platelet aggregability associated with oral contraceptives. Treatment with dipyridamole and aspirin. Mazal S. J Neurol Neurosurg Psychiatry; 1977 Jan 11; 40(1):9-10. PubMed ID: 845612 [Abstract] [Full Text] [Related]
36. Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma. Kahaleh MB, Osborn I, Leroy EC. Ann Intern Med; 1982 May 11; 96(5):610-3. PubMed ID: 6176160 [Abstract] [Full Text] [Related]
37. [Preventive drug therapy of transient cerebral ischemic attacks]. Sørensen PS, Marquardsen J. Ugeskr Laeger; 1982 Aug 09; 144(32):2357-60. PubMed ID: 7147462 [No Abstract] [Full Text] [Related]
38. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome. Tomura S, Ida T, Kuriyama R, Chida Y, Takeuchi J, Motomiya T, Yamazaki H. Clin Nephrol; 1982 Jan 09; 17(1):24-30. PubMed ID: 6459902 [Abstract] [Full Text] [Related]
39. Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial. Serebruany VL, Malinin AI, Sane DC, Jilma B, Takserman A, Atar D, Hennekens CH. Eur J Pharmacol; 2004 Sep 24; 499(3):315-24. PubMed ID: 15381054 [Abstract] [Full Text] [Related]
40. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy. Biller J. J Neurol Sci; 2009 Sep 15; 284(1-2):1-9. PubMed ID: 19380153 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]